Back

P132
Decreasing patchy fibrosis using combined CaMKII inhibition and anti-fibrotic eplerenone treatment tempers arrhythmogenesis in chronic pressure overloaded mice

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Cardiac-specific deletion of myosin phosphatase targeting subunit 2 alleviates cardiac fibrosis in mineralocorticoid receptor-related hypertension
27 August 2023
thumbnail
Congress Presentation
Fibrosis patterns and arrhythmia risk in athletes with dilated left ventricles
4 April 2025
thumbnail
Congress Presentation
The effect of eplerenone on fibrosis in hypertrophic cardiomyopathy. A randomised controlled trial assessed using cardiopulmonary exercise testing and cardiovascular magnetic resonance
1 September 2019
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources